type 2 diabetes mellitus
The drug has been shown to improve glycaemic control in       patients with type 2 diabetes mellitus when used as monotherapy or in combination       with other oral antidiabetic drugs or insulin, and its efficacy is similar to       that of glibenclamide or metformin.
The drug has been shown to improve glycaemic control in        @OBJECT$   @PREDICAT$   @SUBJECT$  when used as monotherapy or in combination       with other oral antidiabetic drugs or insulin, and its efficacy is similar to       that of glibenclamide or metformin.